Host-pathogen interaction in Candida glabrata infection: current knowledge and implications for antifungal therapy.

Expert Review of Anti-infective Therapy
Mubashshir RasheedRupinder Kaur

Abstract

The opportunistic fungal pathogen Candida glabrata poses a clinical challenge in the successful treatment of invasive Candida infections, owing to its low inherent susceptibility toward azole antifungals and the recent acquisition of coresistance toward azole and echinocandin drugs. Compared to other prevalent Candida bloodstream pathogens, C. glabrata neither exhibits secreted proteolytic activity nor invokes a strong immune response in a variety of host cells and is less virulent. It also does not form true hyphae, and the success of C. glabrata, therefore, as a prevalent human fungal pathogen, appears to be built upon a distinct set of virulence attributes. The focus of this review is to outline, in brief, the interaction of C. glabrata with the host, deduced from the knowledge gained from different in vitro, ex vivo, and in vivo model systems. In addition, we briefly discuss the current antifungals, antifungal resistance mechanisms, and the development of new antifungal therapies, along with the available information on the host response. A detailed understanding of stresses, selection pressures and differential immune responses in the presence and absence of antifungals that C. glabrata encounters in varied niches of the h...Continue Reading

References

Oct 1, 1971·Journal of Clinical Pathology·B M PartridgeH I Winner
Oct 1, 1983·Infection and Immunity·S A KlotzM Huppert
Sep 1, 1993·Antimicrobial Agents and Chemotherapy·C A HitchcockD W Warnock
Feb 1, 1996·The Journal of Infectious Diseases·P L FidelJ D Sobel
Jun 20, 1998·Clinical Microbiology Reviews·T C WhiteR A Bowden
Jan 21, 2000·FEMS Immunology and Medical Microbiology·G CotterK Kavanagh
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·Justina Y JuJohn E Bennett
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·Ruth C MatthewsJames Burnie
Jul 2, 2004·Nature·Bernard DujonJean-Luc Souciet
Apr 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jan PachlUNKNOWN Mycograb Invasive Candidiasis Study Group
Apr 26, 2007·Proceedings of the National Academy of Sciences of the United States of America·Rupinder KaurBrendan P Cormack
Sep 15, 2007·FEMS Immunology and Medical Microbiology·Caroline WestwaterEdward Balish
Apr 9, 2008·Molecular Microbiology·Margaret L ZupancicBrendan P Cormack
Aug 13, 2008·Antimicrobial Agents and Chemotherapy·Patrick VandeputteJean-Philippe Bouchara
Oct 10, 2008·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Adam Sutherland, David Ellis
Feb 11, 2009·Proceedings of the National Academy of Sciences of the United States of America·Silvia PolákováJure Piskur
Jul 8, 2009·Infection and Immunity·S Vicky TsoniGordon D Brown
Aug 21, 2009·Mycopathologia·Tomomi SaijoShigeru Kohno
Sep 8, 2009·Journal of Dental Research·L Li, A Dongari-Bagtzoglou
Feb 4, 2010·Proteomics·C Jayampath SeneviratneLakshman P Samaranayake
Apr 3, 2010·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Pirjo PärnänenIsmo Virtanen
Dec 17, 2010·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Sónia SilvaDavid W Williams
Feb 2, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christelle BourgeoisKarl Kuchler
Mar 12, 2011·Nature Reviews. Immunology·Luigina Romani
Jul 6, 2011·FEMS Yeast Research·Chirayu DesaiNeeraj Chauhan
Aug 2, 2011·Mayo Clinic Proceedings·Russell E Lewis
Aug 13, 2011·The Journal of Biological Chemistry·Sapan BorahRupinder Kaur
Aug 19, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katja SeiderBernhard Hube
Aug 31, 2011·F1000 Medicine Reports·Chian-Yong Low, Coleman Rotstein
Apr 25, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eva BärSalomé LeibundGut-Landmann
Dec 21, 2012·Science Translational Medicine·Gordon D BrownTheodore C White
Feb 13, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jessica QuintinDominique Ferrandon

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Ensieh LotfaliFariba Shirvani
Revista chilena de infectología : órgano oficial de la Sociedad Chilena de Infectología
Cecilia Tapia P
Frontiers in Microbiology
Kelley HealeyDavid S Perlin
© 2021 Meta ULC. All rights reserved